Metagenomic Analysis of Bacterial Microbiota in Breast Milk
ConditionBacteria in Breast Milk
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1+
SponsorCentre Hospitalier Sud Francilien
About this trial
The aim of this study is to determine the extent to which bacteria in the breast milk microbiota represent an infectious risk for premature infants, by investigating whether they possess virulence genes, and if so, whether these are expressed or repressed.
Eligibility criteria
Qualifiers
Women of legal age who have given birth at the CHSF (or in another establishment) and whose newborn(s) are being cared for in the CHSF's Neonatal Medicine and Intensive Care Unit,
Women wishing to give their milk to their child,
Parents who have given their consent for the mother-child couple to take part in the study.
Disqualifiers
Mother having received antibiotic therapy in the 3 months prior to delivery, except for those who received injectable antibiotic prophylaxis during delivery.
Trial design
Treatments tested in this trial
- Human breast milk sampling
- Saddle sampling
- Skin sampling
- Saliva sampling
- blood sampling
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov